Gallbladder Cancer
Gallbladder cancer linked to somatic mutations of epidermal growth factor receptor
Published in Health and Medicine Week, June 1st, 2006
According to recent research from Italy, "Conventional therapies are still unsuccessful in patients with carcinoma arising from the biliary tract. Somatic mutations of the EGFR gene and the activation of its downstream pathways predict the sensitivity to small-molecule inhibitors in non-small cell lung carcinoma. Therefore, we analyzed EGFR mutations and related pathways in gallbladder and bile duct carcinomas to consider the possible application of these alternative therapeutic strategies."
"Forty...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
More Articles from Health and Medicine Week
- Basal Cell Carcinoma
Basal cell carcinoma related to ionizing radiation exposure in childhood - Gender Medicine
Evolutionary forces explain why women live longer than men - Health Promotion
Average child lacks 90 minutes of sleep a night - Sexual & Reproductive Health
New male contraceptive targets sperm, not hormones - Skin Cancer
Overexposure to the sun can happen indoors and outdoors, glass filters can help - AIDS-Related Kaposi Sarcoma
MMP inhibitor COL-3 active and well tolerated in AIDS-related Kaposi sarcoma - More from this issue of Health and Medicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
